Quick Answer
Neuraxis, INC reported Stockholders Equity of $3.40 million for the year ending 2025.
- Neuraxis, INC showed an increase of +64.4% in Stockholders Equity from 2024 to 2025.
- This data is from Neuraxis, INC's annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2021 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2022: -$1.98 million | Q2 2022: -$3.49 million | Q3 2022: -$5.56 million | Q1 2023: -$7.75 million | Q2 2023: -$9.98 million | Q3 2023: -$1.06 million | Q1 2024: -$3.18 million | Q2 2024: -$5.26 million | Q3 2024: -$1.79 million | Q1 2025: $258.5 thousand | Q2 2025: $4.25 million | Q3 2025: $2.28 million.
- Over the full 6 years of available data (2021 to 2025), Neuraxis, INC's Stockholders Equity has grown by 511.7%.
- Historical annual values: Fiscal year 2025: $3.40 million | Fiscal year 2024: $2.07 million | Fiscal year 2023: -$1.40 million | Fiscal year 2023: -$1.06 million | Fiscal year 2022: -$5.57 million | Fiscal year 2021: -$825.7 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: